Tricorder? Imperial College Invents Handheld Gene Sequencer
Von: Steven L. (sdlitvin@earthlink.net) [Profil]
Datum: 17.02.2009 20:46
Message-ID: <KsadnUNWmPFijgbUnZ2dnUVZ_sDinZ2d@earthlink.com>
Newsgroup: alt.startrek alt.tv.star-trek.tos
Datum: 17.02.2009 20:46
Message-ID: <KsadnUNWmPFijgbUnZ2dnUVZ_sDinZ2d@earthlink.com>
Newsgroup: alt.startrek alt.tv.star-trek.tos
DNA Electronics spin-out technology is based on the patented Genalysis™ platform capable of delivering real-time, disposable, accurate spot tests for any target nucleic acid sequence (DNA/RNA). Features of this technology include: * state-of-the-art techniques for the monitoring of nucleotide insertions using solid-state biosensors * novel low power electronic techniques, and * methods for on-chip DNA amplification. Fully-integrated lab-on-chip cartridges housing biochemical reagents, advanced microfluidics and low power biosensors are key to DNAe's customisable platform for genetic sequence or genetic mutation detection. The micro-volume gene test reaction taking place on the disposable cartridge is analysed in real-time by a portable handheld device using custom algorithms to ensure a robust and reliable result every time. Genalysis™ cartridges can be tailored to any sequence of interest, human or microbial, making this a customisable semiconductor technology amenable to a wide variety of applications and markets. Application areas The ability to accurately detect a gene sequence in real-time using a standalone, fully portable, low power unit provides end-users with technology as yet unavailable outside a laboratory. This presents opportunities in areas where a real-time answer at the point-of-care can save time, money and lives. * Medical applications include: infectious disease screening, pharmacogenomic personalised medicine, and retail clinic and home-use diagnostics. * Non-medical applications include: agricultural and food industries, forensics, and detection of biological agents where on-the-spot testing is also critical DNA Electronics has identified its key markets in real-time genotype tests for avoiding adverse drug reactions in the rapidly-growing health sector of pharmacogenomics and home and clinic-based diagnosis of infections and viruses in the retail sector. http://tinyurl.com/cm9knm [ Now this is really starting to resemble the 24th century medical tricorder in TNG. ] -- Steven L. Email: sdlitvin@earthlinkNOSPAM.net Remove the NOSPAM before replying to me.[ Auf dieses Posting antworten ]
